
estational Diabetes Mellitus (GDM) is a big problem in pregnancy, hitting about 6% of pregnancies in the United States. It’s key to catch it early and right to keep mom and baby safe. New rules for diagnosing GDM have changed how we check for it.
Healthcare folks know GDM hits different groups in different ways. The new diagnostic criteria for GDM mean we need to keep up with the latest. This helps us act fast to protect mom and baby.
Key Takeaways
- Gestational Diabetes Mellitus affects approximately 6% of pregnancies in the United States.
- Recent updates in diagnostic guidelines have raised glucose thresholds for diagnosing GDM.
- Accurate and timely diagnosis is key to avoiding bad outcomes.
- The rate of GDM changes a lot based on who you are and how you’re checked.
- It’s vital for healthcare pros to know about the latest in diagnosing GDM.
Current Recommendations for Screening for GDM in the United States

In the United States, there are several ways to screen for Gestational Diabetes Mellitus (GDM). The American Diabetes Association (ADA) and the American College of Obstetricians and Gynecologists (ACOG) lead these efforts. They help set the standards for GDM screening.
The ADA and ACOG suggest two main ways to screen for GDM. The two-step method starts with a non-fasting 50-g glucose challenge test (GCT). Then, those who test positive take a 100-g Oral Glucose Tolerance Test (OGTT). This method is widely used and backed by lots of research.
The one-step approach uses a 75-g OGTT. It follows the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria. This method makes screening easier and follows global health guidelines.
| Screening Method | Description | Diagnostic Thresholds |
| Two-Step Method | 50-g GCT followed by 100-g OGTT for positive results | Based on Carpenter-Coustan criteria or similar |
| One-Step Method | 75-g OGTT | IADPSG criteria: Fasting ≥5.1 mmol/L, 1-hour ≥10.0 mmol/L, 2-hour ≥8.5 mmol/L |
It’s important for healthcare providers to know these guidelines. They help find women at risk of GDM early. This way, we can help pregnant women and their babies have better outcomes.
5 Essential GDM Screening Criteria and Diagnostic Guidelines

Getting a correct diagnosis of gestational diabetes (GDM) relies on specific screening criteria and guidelines. We will look at the key factors healthcare providers check when screening for GDM.
1. Standard Screening Timing: Testing After 24 Weeks of Gestation
GDM screening usually happens between 24 and 28 weeks of pregnancy. This timing matches the peak insulin resistance in the second to third trimester.
2. Two-Step Screening Method: Glucose Challenge Test Followed by OGTT
The two-step method starts with a glucose challenge test (GCT). Then, those who screen positive take a diagnostic oral glucose tolerance test (OGTT). This method is common in the United States.
Two-Step Screening Process:
| Step | Description | Threshold |
| 1 | Glucose Challenge Test (GCT) | Typically 50g glucose |
| 2 | Oral Glucose Tolerance Test (OGTT) | Varies; often 100g glucose |
3. One-Step Screening Approach: 75-Gram OGTT
The one-step method uses a 75-gram OGTT. Diagnosis is based on the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria. This simpler method is widely accepted worldwide.
4. IADPSG Diagnostic Thresholds for GDM Diagnosis
The IADPSG criteria set specific thresholds for diagnosis. These include: Fasting plasma glucose (FPG) ≥ 5.1 mmol/L, 1-hour plasma glucose ≥ 10.0 mmol/L, or 2-hour plasma glucose ≥ 8.5 mmol/L. Recent updates suggest FPG: 5.3 – 6.9 mmol/L, 1hPG: ≥10.6 mmol/L, or 2hPG: 9.0 – 11.0 mmol/L.
It’s important to understand these criteria for accurate GDM diagnosis and management. Women with risk factors might need early screening, showing the need for tailored care.
Conclusion
Screening and diagnosing gestational diabetes mellitus is key to avoiding bad pregnancy outcomes. We need to keep up with the latest guidelines to help pregnant women at risk. This ensures they get the best care possible.
The new guidelines help doctors be more precise while keeping patients safe. Using tests like the dm test and pregnancy gtt helps find gestational mellitus early. This way, doctors can manage it well.
As we learn more about gestational diabetes mellitus, sticking to proven practices is vital. This way, we can lower the risk of problems and help both mom and baby have a healthier pregnancy.
FAQ
What is Gestational Diabetes Mellitus (GDM) and how is it diagnosed?
Gestational Diabetes Mellitus is high blood sugar first recognized during pregnancy. It is diagnosed through glucose testing, typically with an oral glucose tolerance test (OGTT), either using a one-step 75-g test or a two-step approach depending on guidelines.
What are the current screening recommendations for GDM in the United States?
The American Diabetes Association recommends universal screening for GDM in all pregnant individuals between 24–28 weeks of gestation, with earlier screening for those at high risk. Screening can follow a one-step 75-g OGTT or a two-step approach with a 50-g glucose challenge followed by a 100-g OGTT if needed.
When is the standard timing for GDM screening during pregnancy?
Standard screening occurs at 24–28 weeks gestation, when insulin resistance naturally increases. High-risk patients may be screened earlier, often during the first trimester, to detect pre-existing hyperglycemia or early-onset GDM.
What are the diagnostic thresholds for GDM diagnosis using the one-step 75-g OGTT?
For the 75-g OGTT, GDM is diagnosed if any of the following plasma glucose values are met or exceeded: fasting ≥92 mg/dL, 1-hour ≥180 mg/dL, or 2-hour ≥153 mg/dL. Only one abnormal value is required for diagnosis.
How do recent updates in diagnostic guidelines, such as the ADIPS 2025 Consensus Recommendations, impact GDM screening?
The 2025 ADIPS Consensus Recommendations emphasize earlier risk-based screening, standardized use of the one-step OGTT, and individualized management. These updates aim to improve detection of GDM and reduce maternal and neonatal complications.
Why is accurate screening and diagnosis of GDM critical during pregnancy?
Accurate diagnosis helps prevent complications such as macrosomia, preterm birth, preeclampsia, and neonatal hypoglycemia. Early identification allows timely interventions like dietary management, glucose monitoring, and insulin therapy if needed.
What are the risk factors that may require early GDM screening?
High-risk factors include obesity, previous GDM, family history of diabetes, advanced maternal age, polycystic ovary syndrome, and certain ethnicities (e.g., Hispanic, South Asian, Native American), which may prompt screening in the first trimester.
How do healthcare providers determine the best screening approach for GDM?
Providers consider patient risk factors, local guidelines, and clinical resources. Low-risk individuals usually follow universal 24–28 week screening, while high-risk patients may undergo early or repeated testing, selecting between one-step or two-step OGTT based on guideline recommendations.
References
https://pmc.ncbi.nlm.nih.gov/articles/PMC4445944